INIS
patients
100%
anticoagulants
61%
plasma
58%
concentration
49%
risks
44%
heparin
36%
laboratories
34%
thrombin
33%
reviews
33%
comparative evaluations
30%
levels
26%
doses
24%
reagents
24%
monitoring
23%
assessments
22%
data
22%
drugs
20%
sensitivity
19%
testing
19%
proteins
18%
tyrosine
18%
kinases
18%
performance
17%
tissues
16%
management
16%
prothrombin
15%
antibodies
14%
thrombosis
13%
in vitro
13%
evaluation
13%
thromboplastin
12%
myeloid leukemia
12%
applications
12%
recommendations
12%
diseases
11%
covid-19
11%
neutrophils
11%
vitamin k
11%
surgery
10%
dimers
10%
values
10%
control
10%
information
8%
validation
8%
peaks
8%
vaccines
8%
molecular weight
8%
coronaviruses
8%
venoms
8%
mass spectrometry
8%
Medicine and Dentistry
Blood Stasis
12%
Heparin
12%
Thrombin
11%
COVID-19
10%
Procoagulant
10%
Platelet
8%
Heparin-Induced Thrombocytopenia
8%
Laboratory Test
7%
D-Dimer
7%
Thrombosis
6%
Venous Thromboembolism
6%
Biological Marker
6%
Fibrinogen
5%
Direct Oral Anticoagulant
5%
Apixaban
5%
Fibrinolysis
5%
Volunteer
5%
Tyrosine-Kinase Inhibitor
5%
Systematic Review
5%
In Vitro
5%
Keyphrases
Del(20q)
5%
Myelodysplasia
5%
Therapeutic Drug Monitoring
5%
Dabigatran
5%
Direct Oral Anticoagulants
5%
Atrial Fibrillation
5%